People · Operator
Named in public records as an officer, director or promoter · active 2016–2025 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Apollo Endosurgery Us Inc | — | Biotechnology | Series C | $175.9M | $2.2B | 2016 |
| Aspira Women's Health Inc. | — | Biotechnology | Series C | $80.0M | $16.6M | 2024 |
| Apollo Endosurgery, Inc. | — | Biotechnology | Series B | $62.4M | $967.9M | 2019 |
STEFANIE CAVANAUGH at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside STEFANIE CAVANAUGH on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Rick Anderson | 2 | 4 |
| Bret Schwartzhoff | 2 | 2 |
| Matthew S. Crawford | 2 | 2 |
| Todd Newton | 2 | 2 |
| Jack Nielsen | 1 | 13 |
| Jeffrey Cohen | 1 | 10 |
| Bruce Robertson | 1 | 7 |
| Jack B. Nielsen | 1 | 6 |
| John Creecy | 1 | 5 |
| James S. Burns | 1 | 5 |
| James Burns | 1 | 4 |
| Dennis McWilliams | 1 | 4 |
| John Barr | 1 | 3 |
| Matthew Crawford | 1 | 3 |
| John F. Hamilton | 1 | 3 |
| John S. Creecy | 1 | 3 |
| Lynn O'Connor Vos | 1 | 3 |
| Daniel L. Kisner | 1 | 3 |
| Thomas McLain | 1 | 2 |
| James Crawford | 1 | 2 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.